Artemisinin protects against dextran sulfate-sodium-induced inflammatory bowel disease, which is associated with activation of the pregnane X receptor-Reference-Cited by-同舟云学术

Artemisinin protects against dextran sulfate-sodium-induced inflammatory bowel disease, which is associated with activation of the pregnane X receptor

Published:2014-09 Issue: Volume:738 Page:273-284
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Hu Donghua,Wang Yuguang,Chen Zhiwu,Ma Zengchun,You Qing,Zhang Xianxie,Zhou Tao,Xiao Yong,Liang Qiande,Tan Hongling,Xiao Chengrong,Tang Xianglin,Zhang Boli,Gao Yue

Funder

National Natural Science Foundation of China

National Basic Research Program of China

Scientific and Technological Major Special Project-Major Creation of New Drugs

Publisher

Elsevier BV

Subject

Pharmacology

Reference36 articles.

1. Elucidating the ‘Jekyll and Hyde’ nature of PXR: the case for discovering antagonists or allosteric antagonists;Biswas;Pharm. Res.,2009

2. Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor;Burk;Mol. Pharmacol.,2005

3. Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity;Cheng;Drug Metab. Dispos.,2009